Alicia Poyser1, Sundeep S Deol1, Lina Osman1, Tharsica Sivagnanasithiyar1, Helen J Kuht2, Roslyn Manrique1, Linda O Okafor1, David Sharpe3, Vijay Savant1, Usman Sarodia1, Nagini Sarvananthan1, Ray Chaudhuri1, Somnath Banerjee1, Joyce Burns1, Mervyn G Thomas4,5. 1. Department of Ophthalmology, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE1 5WW, UK. 2. The University of Leicester Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University of Leicester, RKCSB, PO Box 65, Leicester, LE2 7LX, UK. 3. IT services, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE1 5WW, UK. 4. Department of Ophthalmology, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE1 5WW, UK. mt350@le.ac.uk. 5. The University of Leicester Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University of Leicester, RKCSB, PO Box 65, Leicester, LE2 7LX, UK. mt350@le.ac.uk.
We read with interest, the article ‘The impact of COVID policies on acute ophthalmology services–experiences from Moorfields Eye Hospital NHS Foundation Trust’ [1]. The paper emphasises disparity between attendance to A&E prior-to and during the COVID-19 outbreak. Interestingly, the authors observe a reduction in the number of patients presenting with retinal detachments (RD) during COVID19 lockdown period. However, further analysis on status of the macula (on versus off), number of cases of posterior vitreous detachments (PVD) and retinal tears have not been described in the report.At the University Hospitals Leicester, we compared presentations of vitreoretinal pathologies to our emergency eye department (EED) during the COVID-19 pandemic against an equivalent period in 2019. Data of EED attendance from electronic patient records were extracted over a 31-day period during: (study period 1 (SP1)) COVID-19 pandemic lockdown in UK (24th March 2020–23rd April 2020) and (study period 2 (SP2)) the equivalent 2019 period (24th March 2019–23rd April 2019). This included a total of 853 patients (403 females, 449 males; mean age ± SD = 48.5 ± 20.0 years) from SP1, and 1818 patients’ (969 females, 849 males; 49.0 ± 22.1 years) from SP2.A 53% reduction in EED attendance was noted between SP1 and SP2. We observed a 60% reduction in the number of retinal tears presenting to EED during SP1 (n = 6) compared to SP2 (n = 15). Similarly, we had a 64.9% reduction in PVD presenting between SP1 (n = 46) and SP2 (n = 131). We observed a 65.7% reduction in number of RD between SP1 and SP2. There was a significantly (X2 = 6.66, p = 0.0099) higher proportion of macula-off RD (84.6% of all RD) during SP1 when compared to SP2 (42.9%) (Fig. 1).
Fig. 1
Vitreoretinal pathologies presenting to the eye emergency department.
Reduced number of cases were seen for posterior vitreous detachments (PVD) (a) retinal tears (b) and retinal detachment (c) during COVID19 related lockdown in the UK compared against an equivalent period in 2019. The proportion of macula off retinal detachments was significantly higher during lockdown (c).
Vitreoretinal pathologies presenting to the eye emergency department.
Reduced number of cases were seen for posterior vitreous detachments (PVD) (a) retinal tears (b) and retinal detachment (c) during COVID19 related lockdown in the UK compared against an equivalent period in 2019. The proportion of macula off retinal detachments was significantly higher during lockdown (c).Our work supports the authors’ initial observations and expands on this by showing higher proportion of macula-off RD and lower number of retinal tears during SP1 suggestive of delayed presentation in these cases. This raises concerns about increased morbidity from ocular pathology unrelated directly to COVID19. We anticipate additional pressures on EED and vitreoretinal services due to complications and associated morbidity from delayed presentations.
Authors: Louisa Wickham; Gordon Hay; Robin Hamilton; Jack Wooding; Harry Tossounis; Lyndon da Cruz; Dilani Siriwardena; Nick Strouthidis Journal: Eye (Lond) Date: 2020-05-13 Impact factor: 4.456
Authors: Amirhossein Roshanshad; Mohammad Ali Ashraf; Romina Roshanshad; Ali Kharmandar; Seyed Alireza Zomorodian; Hossein Ashraf Journal: J Ophthalmic Vis Res Date: 2021-04-29
Authors: Parnian Arjmand; Fahmeeda Murtaza; Arshia Eshtiaghi; Marko M Popovic; Peter J Kertes; Kenneth T Eng Journal: Can J Ophthalmol Date: 2020-12-26 Impact factor: 1.882